OBJECTIVE: To report the efficacy of extracorporeal life support (ECLS) in acute carbamazepine poisoning with sustained refractory myocardial failure and a high degree of conductance disturbances. DESIGN AND SETTING: Case report from the toxicological and medical intensive care unit in a university hospital. PATIENT: A 26-year-old man with severe myocardial failure unresponsive to 1.7 microg kg(-1) min(-1) epinephrine and 1.9 microg kg(-1) min(-1) norepinephrine (SvO2, 17.8% and cardiac index, 0.8 l min(-1) m(-2)) following a suicidal ingestion of 32 g slow-release carbamazepine. INTERVENTIONS: ECLS (Jostra-Maquet centrifugal pump (Rotaflow) connected to a hollow-fiber membrane oxygenator). MEASUREMENTS AND RESULTS: ECLS device allowed inotropic drug weaning while maintaining end-organ function and supported the patient until myocardial recovery. The plasma carbamazepine level was 224 micromol/l on admission and peaked at 338 micromol/l 101 h after admission with a prolonged gastrointestinal absorption phase despite multiple doses of activated charcoal. The patient survived and was successfully explanted on day 6. An extensive and regressive thrombosis of the inferior vena cava was noted. Cardiac function totally recovered and at 2-year follow-up. There were no significant sequelae. CONCLUSIONS: We report a case of life-threatening myocardial failure with conductance disturbances secondary to an acute carbamazepine poisoning, demonstrating the efficacy of ECLS to assist recovery.
OBJECTIVE: To report the efficacy of extracorporeal life support (ECLS) in acute carbamazepinepoisoning with sustained refractory myocardial failure and a high degree of conductance disturbances. DESIGN AND SETTING: Case report from the toxicological and medical intensive care unit in a university hospital. PATIENT: A 26-year-old man with severe myocardial failure unresponsive to 1.7 microg kg(-1) min(-1) epinephrine and 1.9 microg kg(-1) min(-1) norepinephrine (SvO2, 17.8% and cardiac index, 0.8 l min(-1) m(-2)) following a suicidal ingestion of 32 g slow-release carbamazepine. INTERVENTIONS: ECLS (Jostra-Maquet centrifugal pump (Rotaflow) connected to a hollow-fiber membrane oxygenator). MEASUREMENTS AND RESULTS: ECLS device allowed inotropic drug weaning while maintaining end-organ function and supported the patient until myocardial recovery. The plasma carbamazepine level was 224 micromol/l on admission and peaked at 338 micromol/l 101 h after admission with a prolonged gastrointestinal absorption phase despite multiple doses of activated charcoal. The patient survived and was successfully explanted on day 6. An extensive and regressive thrombosis of the inferior vena cava was noted. Cardiac function totally recovered and at 2-year follow-up. There were no significant sequelae. CONCLUSIONS: We report a case of life-threatening myocardial failure with conductance disturbances secondary to an acute carbamazepinepoisoning, demonstrating the efficacy of ECLS to assist recovery.
Authors: Wilma E Monteban-Kooistra; Maarten P van den Berg; Jaap E Tulleken; Jack J M Ligtenberg; John H J M Meertens; Jan G Zijlstra Journal: Intensive Care Med Date: 2006-01-24 Impact factor: 17.440
Authors: Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde Journal: Heart Rhythm Date: 2009-07-08 Impact factor: 6.343
Authors: Arnon Adler; Guy Topaz; Karin Heller; David Zeltser; Tami Ohayon; Uri Rozovski; Amir Halkin; Raphael Rosso; Shay Ben-Shachar; Charles Antzelevitch; Sami Viskin Journal: Heart Rhythm Date: 2013-07-19 Impact factor: 6.343
Authors: Marc Ghannoum; Christopher Yates; Tais F Galvao; Kevin M Sowinski; Thi Hai Vân Vo; Andrew Coogan; Sophie Gosselin; Valery Lavergne; Thomas D Nolin; Robert S Hoffman Journal: Clin Toxicol (Phila) Date: 2014-10-30 Impact factor: 4.467